Cellebrite Raises 2026 Adjusted EBITDA Outlook to $163M–$166M
Cellebrite reported Q3 net income of $26.7 million and adjusted EBITDA of $53.6 million, with ARR growth of 20%. It reaffirmed its full-year ARR outlook.
Cellebrite reported Q3 net income of $26.7M and adjusted EBITDA of $53.6M, with ARR growth of 20%. It raised its 2026 adjusted EBITDA outlook to $163M—$166M and reaffirmed its full-year ARR outlook.Material DetailsContext by AI AnalystThis is a quarterly results update with reported growth and prof…